Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
Gynecologic Oncology|February 1, 1994
Prospective randomized trial of LLETZ versus laser ablation in patients with cervical intraepithelial neoplasiaR D Alvarez, C W Helm, R P Edwards, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1996
Intraperitoneal radioimmunotherapy of ovarian cancer with lutetium-177-CC49R F Meredith, E E Partridge, R D Alvarez, et al.
Developments in Biologicals|January 5, 2002
Viral latency--the papillomavirus modelT R Broker, G Jin, A Croom-Rivers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2000
A cancer gene therapy approach utilizing an anti-erbB-2 single-chain antibody-encoding adenovirus (AD21): a phase I trialR D Alvarez, M N Barnes, J Gomez-Navarro, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 25, 2007
A multi-institutional evaluation of factors predictive of toxicity and efficacy of bevacizumab for recurrent ovarian cancerJ D Wright, A A Secord, T M Numnum, et al.
Gene Therapy|February 8, 2005
Evaluation of tumor-specific promoter activities in melanomaB Lu, S K Makhija, D M Nettelbeck, et al.
Gynecologic Oncology|April 1, 1997
Intraperitoneal radioimmunotherapy of ovarian cancer with 177Lu-CC49: a phase I/II studyR D Alvarez, E E Partridge, M B Khazaeli, et al.
Cancer Biotherapy & Radiopharmaceuticals|October 18, 2001
Intraperitoneal radioimmunochemotherapy of ovarian cancer: a phase I studyR F Meredith, R D Alvarez, E E Partridge, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 8, 2001
An adenovirus with enhanced infectivity mediates molecular chemotherapy of ovarian cancer cells and allows imaging of gene expressionA Hemminki, N Belousova, K R Zinn, et al.
Pageof 10